William J. Catàlona

51.5k total citations · 10 hit papers
547 papers, 31.2k citations indexed

About

William J. Catàlona is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Rheumatology. According to data from OpenAlex, William J. Catàlona has authored 547 papers receiving a total of 31.2k indexed citations (citations by other indexed papers that have themselves been cited), including 392 papers in Pulmonary and Respiratory Medicine, 146 papers in Surgery and 108 papers in Rheumatology. Recurrent topics in William J. Catàlona's work include Prostate Cancer Diagnosis and Treatment (340 papers), Prostate Cancer Treatment and Research (317 papers) and Urologic and reproductive health conditions (105 papers). William J. Catàlona is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (340 papers), Prostate Cancer Treatment and Research (317 papers) and Urologic and reproductive health conditions (105 papers). William J. Catàlona collaborates with scholars based in United States, Netherlands and Canada. William J. Catàlona's co-authors include Deborah S. Smith, Timothy L. Ratliff, Kimberly A. Roehl, Stacy Loeb, M’Liss A. Hudson, Gerald L. Andriole, Peter A. Humphrey, Jo Ann V. Antenor, Misop Han and Gustavo Franco Carvalhal and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

William J. Catàlona

531 papers receiving 29.3k citations

Hit Papers

Measurement of Prostate-Specific Antigen in Serum as a Sc... 1989 2026 2001 2013 1991 1994 2004 1992 1995 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer
    1991 1.8k citations William J. Catàlona, Deborah S. Smith et al. profile →
  2. Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 Men
    1994 1.1k citations William J. Catàlona, Frederick R. Ahmann et al. The Journal of Urology profile →
  3. CANCER PROGRESSION AND SURVIVAL RATES FOLLOWING ANATOMICAL RADICAL RETROPUBIC PROSTATECTOMY IN 3,478 CONSECUTIVE PATIENTS: LONG-TERM RESULTS
    2004 685 citations William J. Catàlona et al. The Journal of Urology profile →
  4. Incidence and Treatment of Complications of Bacillus Calmette-Guerin Intravesical Therapy in Superficial Bladder Cancer
    1992 597 citations William J. Catàlona et al. The Journal of Urology profile →
  5. Evaluation of Percentage of Free Serum Prostate-Specific Antigen to Improve Specificity of Prostate Cancer Screening
    1995 545 citations William J. Catàlona profile →
  6. Preoperative PSA Velocity and the Risk of Death from Prostate Cancer after Radical Prostatectomy
    2004 529 citations William J. Catàlona et al. profile →
  7. POTENCY, CONTINENCE AND COMPLICATION RATES IN 1,870 CONSECUTIVE RADICAL RETROPUBIC PROSTATECTOMIES
    1999 525 citations William J. Catàlona, Gustavo Franco Carvalhal et al. The Journal of Urology profile →
  8. Serial Prostatic Biopsies in Men with Persistently Elevated Serum Prostate Specific Antigen Values
    1994 447 citations William J. Catàlona, Deborah S. Smith et al. The Journal of Urology profile →
  9. Clinical use of Prostate Specific Antigen in Patients with Prostate Cancer
    1989 418 citations M’Liss A. Hudson, William J. Catàlona et al. The Journal of Urology profile →
  10. Time Trends and Variation in the Use of Active Surveillance for Management of Low-risk Prostate Cancer in the US
    2023 70 citations Matthew R. Cooperberg, William Meeks et al. JAMA Network Open profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William J. Catàlona United States 90 20.9k 8.0k 6.7k 4.8k 4.4k 547 31.2k
David G. Bostwick United States 90 16.2k 0.8× 5.7k 0.7× 6.2k 0.9× 6.6k 1.4× 3.7k 0.8× 458 27.2k
Alan W. Partin United States 94 31.0k 1.5× 6.5k 0.8× 7.9k 1.2× 7.6k 1.6× 4.9k 1.1× 657 40.3k
Eric A. Klein United States 88 19.7k 0.9× 6.0k 0.7× 3.5k 0.5× 5.0k 1.0× 4.8k 1.1× 733 29.8k
Rodolfo Montironi Italy 77 16.3k 0.8× 10.3k 1.3× 4.3k 0.6× 9.7k 2.0× 5.9k 1.3× 877 30.3k
Theodorus van der Kwast Netherlands 86 20.0k 1.0× 7.9k 1.0× 4.4k 0.7× 8.2k 1.7× 5.1k 1.1× 651 32.9k
Patrick C. Walsh United States 104 29.5k 1.4× 8.0k 1.0× 9.4k 1.4× 5.8k 1.2× 3.9k 0.9× 577 40.5k
Michael L. Blute United States 100 28.4k 1.4× 9.7k 1.2× 3.8k 0.6× 13.0k 2.7× 6.6k 1.5× 507 36.2k
John T. Wei United States 73 13.3k 0.6× 4.9k 0.6× 4.5k 0.7× 4.7k 1.0× 3.4k 0.8× 378 23.7k
Michael Marberger Austria 76 11.7k 0.6× 5.0k 0.6× 3.4k 0.5× 4.4k 0.9× 1.8k 0.4× 502 20.6k
James E. Montie United States 70 10.1k 0.5× 8.2k 1.0× 1.9k 0.3× 4.7k 1.0× 3.9k 0.9× 459 20.8k

Countries citing papers authored by William J. Catàlona

Since Specialization
Citations

This map shows the geographic impact of William J. Catàlona's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William J. Catàlona with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William J. Catàlona more than expected).

Fields of papers citing papers by William J. Catàlona

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William J. Catàlona. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William J. Catàlona. The network helps show where William J. Catàlona may publish in the future.

Co-authorship network of co-authors of William J. Catàlona

This figure shows the co-authorship network connecting the top 25 collaborators of William J. Catàlona. A scholar is included among the top collaborators of William J. Catàlona based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William J. Catàlona. William J. Catàlona is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hao, Yangyang, Mohammed Alshalalfa, J. Proudfoot, et al.. (2025). Tumor necrosis factor alpha signaling activity and NCCN risk, adverse pathology, and progression during active surveillance in prostate cancer.. Journal of Clinical Oncology. 43(5_suppl). 415–415. 1 indexed citations
2.
3.
Sundaresan, Vinaik, Rong Wang, Jessica B. Long, et al.. (2024). Associations Between Prostate Magnetic Resonance Imaging, Genomic Testing, and Treatment for Localized Prostate Cancer. Urology Practice. 11(6). 965–973. 1 indexed citations
4.
Sundaresan, Vinaik, James A. Bailey, Paweł Rajwa, et al.. (2024). Risks of grade reclassification among patients with Gleason grade group 1 prostate cancer and PI-RADS 5 findings on prostate MRI. Urologic Oncology Seminars and Original Investigations. 43(3). 193.e19–193.e26. 1 indexed citations
5.
Cooperberg, Matthew R., William Meeks, Raymond Fang, et al.. (2023). Time Trends and Variation in the Use of Active Surveillance for Management of Low-risk Prostate Cancer in the US. JAMA Network Open. 6(3). e231439–e231439. 70 indexed citations breakdown →
6.
Lü, Xiaodong, Ka-wing Fong, Galina Gritsina, et al.. (2022). HOXB13 suppresses de novo lipogenesis through HDAC3-mediated epigenetic reprogramming in prostate cancer. Nature Genetics. 54(5). 670–683. 58 indexed citations
7.
Leapman, Michael S., Janet E. Cowan, Hao G. Nguyen, et al.. (2017). Active Surveillance in Younger Men With Prostate Cancer. Journal of Clinical Oncology. 35(17). 1898–1904. 36 indexed citations
8.
Lindquist, Karla, Pamela L. Paris, Thomas J. Hoffmann, et al.. (2016). Mutational Landscape of Aggressive Prostate Tumors in African American Men. Cancer Research. 76(7). 1860–1868. 54 indexed citations
9.
Oberlin, Daniel T., David D. Casalino, Frank H. Miller, et al.. (2016). Diagnostic Value of Guided Biopsies: Fusion and Cognitive-registration Magnetic Resonance Imaging Versus Conventional Ultrasound Biopsy of the Prostate. Urology. 92. 75–79. 49 indexed citations
10.
Catàlona, William J.. (2012). The argument to continue prostate cancer screening, early detection.
11.
Zhang, Qiang, Brian T. Helfand, Thomas L. Jang, et al.. (2009). Nuclear Factor-κB-Mediated Transforming Growth Factor-β-Induced Expression of Vimentin Is an Independent Predictor of Biochemical Recurrence after Radical Prostatectomy. Clinical Cancer Research. 15(10). 3557–3567. 93 indexed citations
12.
Ding, Yongzeng, Li Xu, Shan Chen, et al.. (2006). Gene profiling of genistein’s effect in men with prostate cancer.. Cancer Research. 66. 1234–1235. 1 indexed citations
13.
Xu, Jianfeng, Deborah A. Meyers, David A. Sterling, et al.. (2002). Association studies of serum prostate-specific antigen levels and the genetic polymorphisms at the androgen receptor and prostate-specific antigen genes.. PubMed. 11(7). 664–9. 40 indexed citations
14.
Naughton, C.K., David K. Ornstein, Deborah S. Smith, & William J. Catàlona. (2000). PAIN AND MORBIDITY OF TRANSRECTAL ULTRASOUND GUIDED PROSTATE BIOPSY: A PROSPECTIVE RANDOMIZED TRIAL OF 6 VERSUS 12 CORES. The Journal of Urology. 163(1). 168–171. 155 indexed citations
15.
Smith, Deborah S., et al.. (2000). Quality-of-life outcomes for men with prostate carcinoma detected by screening. Cancer. 88(6). 1454–1463. 82 indexed citations
16.
Smith, Deborah S., et al.. (2000). Quality‐of‐life outcomes for men with prostate carcinoma detected by screening. Cancer. 88(6). 1454–1463. 4 indexed citations
17.
Richie, Jerome P., William J. Catàlona, Frederick R. Ahmann, et al.. (1993). Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination. Urology. 42(4). 365–374. 154 indexed citations
18.
Catàlona, William J., Donald S. Coffey, & James P. Karr. (1989). Clinical aspects of prostate cancer : assessment of new diagnostic and management procedures : proceedings of a workshop of the Prostate Cancer Working Group of the National Cancer Institute's Organ Systems Program, held October 16-19, 1988, at Prout's Neck, Maine, U.S.A.. Elsevier eBooks. 2 indexed citations
19.
Biondetti, Pietro, JK Lee, D Ling, & William J. Catàlona. (1987). Clinical stage B prostate carcinoma: staging with MR imaging.. Radiology. 162(2). 325–329. 83 indexed citations
20.
McCool, Robert E., William J. Catàlona, Marlyn P. Langford, & Timothy L. Ratliff. (1981). Induction of human gamma interferon by protein A from Staphylococcus aureus. Journal of Interferon Research. 1(4). 473–481. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David G. Bostwick Breakdown of academic impact, for papers by Alan W. Partin Breakdown of academic impact, for papers by Eric A. Klein Breakdown of academic impact, for papers by Rodolfo Montironi Breakdown of academic impact, for papers by Theodorus van der Kwast Breakdown of academic impact, for papers by Patrick C. Walsh Breakdown of academic impact, for papers by Michael L. Blute Breakdown of academic impact, for papers by John T. Wei Breakdown of academic impact, for papers by Michael Marberger Breakdown of academic impact, for papers by James E. Montie
Rankless by CCL
2026